Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries.

Orsi F, d'almeida C.

Curr Opin HIV AIDS. 2010 May;5(3):237-41. doi: 10.1097/COH.0b013e32833860ba. Review.

PMID:
20539080
2.

A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.

Waning B, Diedrichsen E, Moon S.

J Int AIDS Soc. 2010 Sep 14;13:35. doi: 10.1186/1758-2652-13-35.

3.

Trends and economic stress: a challenge to universal access to antiretroviral treatment in India.

Dhamija P, Bansal D, Medhi B.

Curr HIV Res. 2009 Jul;7(4):410-7.

PMID:
19601776
4.

TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.

Orsi F, D'Almeida C, Hasenclever L, Camara M, Tigre P, Coriat B.

AIDS. 2007 Oct 1;21(15):1997-2003. Review. No abstract available.

PMID:
17885289
5.

A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.

Pinheiro Edos S, Antunes OA, Fortunak JM.

Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Review.

PMID:
18571246
6.

Intellectual property rights, market competition and access to affordable antiretrovirals.

Pascual F.

Antivir Ther. 2014;19 Suppl 3:57-67. doi: 10.3851/IMP2901. Review.

PMID:
25309984
7.

Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?

Dionisio D, Cao Y, Hongzhou L, Kraisintu K, Messeri D.

Curr HIV Res. 2006 Jan;4(1):3-20. Review.

PMID:
16454707
8.
9.

Driving a decade of change: HIV/AIDS, patents and access to medicines for all.

Hoen E', Berger J, Calmy A, Moon S.

J Int AIDS Soc. 2011 Mar 27;14:15. doi: 10.1186/1758-2652-14-15. Review.

10.

Drug resistance, patent resistance: Indian pharmaceuticals and the impact of a new patent regime.

Halliburton M.

Glob Public Health. 2009;4(6):515-27. doi: 10.1080/17441690902796449.

PMID:
19548158
11.

Examining the production costs of antiretroviral drugs.

Pinheiro E, Vasan A, Kim JY, Lee E, Guimier JM, Perriens J.

AIDS. 2006 Aug 22;20(13):1745-52.

PMID:
16931939
12.

Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment.

Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA.

PLoS Med. 2007 Nov 13;4(11):e305.

13.

Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?

Meiners C, Sagaon-Teyssier L, Hasenclever L, Moatti JP.

PLoS One. 2011;6(8):e23478. doi: 10.1371/journal.pone.0023478.

14.
15.

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand.

Ford N, Wilson D, Costa Chaves G, Lotrowska M, Kijtiwatchakul K.

AIDS. 2007 Jul;21 Suppl 4:S21-9. Review.

PMID:
17620749
16.

Managing the effect of TRIPS on availability of priority vaccines.

Milstien J, Kaddar M.

Bull World Health Organ. 2006 May;84(5):360-5.

17.

The economics of effective AIDS treatment in Thailand.

Over M, Revenga A, Masaki E, Peerapatanapokin W, Gold J, Tangcharoensathien V, Thanprasertsuk S.

AIDS. 2007 Jul;21 Suppl 4:S105-16.

PMID:
17620745
18.

The role of intellectual property rights in treatment access: challenges and solutions.

't Hoen E, Passarelli CA.

Curr Opin HIV AIDS. 2013 Jan;8(1):70-4. doi: 10.1097/COH.0b013e32835b6e5a. Review.

PMID:
23201855
19.

What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?

Dionisio D, Gass R, McDermott P, Racalbuto V, Madeo M, Braghieri G, Crowley S, Pinheiro Edos S, Graaff P, Vasan A, Eksaengsri A, Moller H, Khanna AK, Kraisintu K, Juneja S, Nicolaou S, Sengupta A, Esperti F, Messeri D.

Curr HIV Res. 2007 Mar;5(2):155-87.

PMID:
17346132
20.

Companies reduce prices for HIV drugs in developing countries.

Gottlieb S.

Bull World Health Organ. 2000;78(6):862.

Items per page

Supplemental Content

Support Center